Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
We’ve published a new article on how to make STI testing routine and stigma-free.
👉 Read here: bit.ly/3VmDGTo
#SexualHealth #TestingWeek
#SexualHealth #TestingWeek
We’ve published a new article on how to make STI testing routine and stigma-free.
👉 Read here: bit.ly/3VmDGTo
#SexualHealth #TestingWeek
#SexualHealth #TestingWeek
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
Smartkits = a smarter fix.
63% of SHL users used to test outside their borough. Now they test at home, cutting down cross-charging and saving £££ across London.
📄 bit.ly/4f06r1j
#Smartkits #PublicHealth #CostSaving #SexualHealth #SHL
Smartkits = a smarter fix.
63% of SHL users used to test outside their borough. Now they test at home, cutting down cross-charging and saving £££ across London.
📄 bit.ly/4f06r1j
#Smartkits #PublicHealth #CostSaving #SexualHealth #SHL
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
MHRA warns 'skinny jabs' may reduce the effectiveness of the pill and cause potential risks during pregnancy.
Full info here: bit.ly/43OXmmy
#SexualHealth #Contraception #MHRA #Wegovy #Saxenda
MHRA warns 'skinny jabs' may reduce the effectiveness of the pill and cause potential risks during pregnancy.
Full info here: bit.ly/43OXmmy
#SexualHealth #Contraception #MHRA #Wegovy #Saxenda
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
bit.ly/4kWdGcq
bit.ly/4kWdGcq
bit.ly/4kWdGcq
At the London Sexual Health Programme, we champion inclusive, stigma-free care.
From SHL.UK’s discreet home testing to getting PrEP into clinics, we’re here for the LGBTQIA+ community .
#PrideMonth #LGBTQIAHealth
At the London Sexual Health Programme, we champion inclusive, stigma-free care.
From SHL.UK’s discreet home testing to getting PrEP into clinics, we’re here for the LGBTQIA+ community .
#PrideMonth #LGBTQIAHealth
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics
In liver disease care this approach is not only justified, it is essential.
👉 Reduce late-stage emergency presentations.
👉 Enable more timely & appropriate referrals.
👉 Improve operational efficiency.
👉 Ensure better patient outcomes.
In liver disease care this approach is not only justified, it is essential.
👉 Reduce late-stage emergency presentations.
👉 Enable more timely & appropriate referrals.
👉 Improve operational efficiency.
👉 Ensure better patient outcomes.
It's often silent until it's too late.
Early detection through case-finding can save lives and reduce pressure on the NHS. Public health has a real role to play.
#PublicHealth #LiverDisease #NHS
It's often silent until it's too late.
Early detection through case-finding can save lives and reduce pressure on the NHS. Public health has a real role to play.
#PublicHealth #LiverDisease #NHS
We're dedicated to helping clinicians diagnose rare liver diseases earlier, using hepatoSIGHT™, & supporting patients to get the care they need as soon as possible.
#RareDiseaseDay #LiverDisease
We're dedicated to helping clinicians diagnose rare liver diseases earlier, using hepatoSIGHT™, & supporting patients to get the care they need as soon as possible.
#RareDiseaseDay #LiverDisease
1️⃣ Data preparation.
2️⃣ Search criteria.
3️⃣ Results.
4️⃣ Clinical follow-up.
How does case-finding improve the #liverdisease care pathway?
👉 Risk-stratification.
👉 Utilises existing resources.
👉 Improves outcomes.
💡 predictivehealthintelligence.co.uk/professional...
1️⃣ Data preparation.
2️⃣ Search criteria.
3️⃣ Results.
4️⃣ Clinical follow-up.
How does case-finding improve the #liverdisease care pathway?
👉 Risk-stratification.
👉 Utilises existing resources.
👉 Improves outcomes.
💡 predictivehealthintelligence.co.uk/professional...